Skip to main content
Clinical Trials/NL-OMON41543
NL-OMON41543
Recruiting
N/A

Translation, cross-cultural adaptation and validation of questionnaires for Turkish and Moroccan Dutch patients with mood, anxiety and/or somatoform disorders and a comparison between native Dutch and Turkish and Moroccan immigrant patients - Leiden Routine Outcome Monitoring Study for Moroccan and Turkish immigrants

eids Universitair Medisch Centrum0 sites570 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
angst- en somatoforme stoornissen
Sponsor
eids Universitair Medisch Centrum
Enrollment
570
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • For the pilot\- and validation study:\*
  • Patients and healthy participants eligible for this study are: (1\) those who have moderate mood, anxiety and/or somatoform (MAS) symptoms (applies only to patients); (2\) those who are born in Turkey or Morocco or have at least one parent or a grandparent born in Turkey or Morocco; (3\) between 18 and 65 years old; and (4\) proficient in the Moroccan Arabic, Tarifit or Turkish language.\*\*
  • All Moroccan and Turkish patients who are referred for treatment of mood, anxiety and/or somatoform (MAS) symptoms to Rivierduinen, RIAGG Rijdmond or i\-psy Amsterdam will be approached to participate in this research, whether or not they are diagnosed with a MAS disorder.\*\* ;For focus groups:\*
  • Healthy participants eligible for this study are: (1\) those who are born in Turkey or Morocco or have at least one parent or a grandparent born in Turkey or Morocco; (2\) between 18 and 65 years old; (3\) proficient in the Moroccan Arabic, Tarifit or Turkish language; and (4\) proficient in the Dutch language.;For comparative study:\*
  • Patients eligible for this study are: (1\) between 18 and 65 years old; (2\) have a Dutch, Moroccan or Turkish ethnic background; (3\) proficient in the Dutch, the Moroccan Arabic, Tarifit, or Turkish language; and (4\) referred for MAS symptoms to Rivierduinen, RIAGG Rijnmond, or i\-psy Amsterdam, whether or not they are diagnosed with a MAS disorder.

Exclusion Criteria

  • For the pilot\- and validation study\*:
  • The following patients are excluded: (1\) patients who have insufficient proficiency in the Moroccan Arabic, Tarifit or Turkish language; (2\) patients with a primary psychiatric disorder other than a mood, anxiety and/or somatoform disorder; (3\) with severe psychiatric problems; (4\) patients with suicidal ideations; or (5\) patients who display major impairment in social functioning.;The following healthy participants are excluded: who have insufficient proficiency in the Moroccan Arabic, Tarifit or Turkish language.;For focus groups:
  • There are no exclusion criteria.\*\*;For comparative research:\*
  • The following patients are excluded: (1\) Patients with a primary psychiatric disorder other than a mood, anxiety and/or somatoform disorder; (2\) patients with severe psychiatric problems; (3\) patients with suicidal ideations; or (4\) patients who display major impairment in social functioning.

Outcomes

Primary Outcomes

Not specified

Similar Trials